Revenue | ₹3,418.68Cr |
Net Profits | ₹347.96Cr |
Net Profit Margins | 10.18% |
Glenmark Pharmaceuticals Ltd’s revenue jumped 28% since last year same period to ₹3,418.68Cr in the Q3 2024-2025. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated -1.57% fall in its revenue since last 3-months.
Glenmark Pharmaceuticals Ltd’s net profit jumped 199.03% since last year same period to ₹347.96Cr in the Q3 2024-2025. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated -1.76% fall in its net profits since last 3-months.
Glenmark Pharmaceuticals Ltd’s net profit margin jumped 177.37% since last year same period to 10.18% in the Q3 2024-2025. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated -0.2% fall in its net profit margins since last 3-months.
The revenue for Glenmark Pharmaceuticals Ltd in the Q3 results 2024 was ₹3,418.68Cr.
The net profit for Glenmark Pharmaceuticals Ltd in the Q3 results 2024 was ₹347.96Cr.
The net profit margin for Glenmark Pharmaceuticals Ltd in the Q3 results 2024 was 10.18%.
The revenue for Glenmark Pharmaceuticals Ltd in the Q3 results 2023 was ₹2,670.88Cr.
The net profit for Glenmark Pharmaceuticals Ltd in the Q3 results 2023 was ₹-351.37Cr.
The net profit margin for Glenmark Pharmaceuticals Ltd in the Q3 results 2023 was -13.16%.